NOTCH4 and DLL4

  • Number of citations: 0 (PubMedID 12814948)
  • Data Source: HPRD (in vitro, in vivo)

NOTCH4

DLL4

Name notch receptor 4 delta like canonical Notch ligand 4
Structure PDB 7OR3 PDB 5MVX
GO Annotations Cellular Component
Molecular Function
Biological Process
Pathways
GWAS
  • A body shape index ( 34021172 )
  • Age-related macular degeneration ( 22694956 )
  • Aspartate aminotransferase levels ( 29403010 )
  • Asthma ( 21804548 31619474 )
  • Autism spectrum disorder or schizophrenia ( 28540026 )
  • Bipolar disorder ( 31043756 )
  • Blood protein levels in cardiovascular risk ( 28369058 )
  • Chronic hepatitis B infection ( 25802187 )
  • Circulating myeloperoxidase levels (serum) ( 23620142 )
  • Clozapine-induced agranulocytosis/granulocytopenia in treatment-resistant schizophrenia ( 26876947 )
  • Colorectal cancer ( 30529582 )
  • Crohn's disease ( 23266558 )
  • Epstein-Barr virus immune response (EBNA-1) ( 23326239 )
  • Femur bone mineral density x serum urate levels interaction ( 34046847 )
  • Food antigen IgG levels ( 24962563 )
  • Hematocrit ( 32888494 )
  • Hemoglobin ( 32888494 )
  • High light scatter reticulocyte count ( 32888494 )
  • Hip circumference adjusted for BMI ( 34021172 )
  • HIV-1 control ( 20041166 )
  • Inflammatory bowel disease ( 28067908 )
  • Iron status biomarkers (iron levels) ( 28334935 )
  • Joint mobility (Beighton score) ( 27182965 )
  • Longevity ( 30294719 )
  • Lung cancer ( 31577861 28604730 )
  • Lung cancer in ever smokers ( 28604730 )
  • Lupus nephritis in systemic lupus erythematosus ( 24925725 )
  • Migraine ( 27322543 )
  • Mixed cryoglobulinemia vasculitis in chronic hepatitis C infection ( 25030430 )
  • Obesity-related traits ( 23251661 )
  • Objective response to lithium treatment in bipolar disorder ( 26503763 )
  • Prostate cancer ( 23535732 )
  • Reticulocyte count ( 32888494 )
  • Reticulocyte fraction of red cells ( 27863252 )
  • Sarcoidosis (non-Lofgren's syndrome without extrapulmonary manifestations) ( 26651848 )
  • Schizophrenia ( 23894747 19571808 30285260 )
  • Soluble receptor for advanced glycation end-product levels ( 26083729 )
  • Squamous cell lung carcinoma ( 28604730 )
  • Systemic lupus erythematosus ( 32771030 21408207 )
  • Systemic sclerosis ( 21779181 )
  • Takayasu arteritis ( 25604533 )
  • Type 1 diabetes (age at diagnosis) ( 33179336 )
  • Type 1 diabetes and autoimmune thyroid diseases ( 25936594 )
  • Ulcerative colitis ( 28067908 24837172 )
  • Waist circumference adjusted for body mass index ( 34021172 )
  • Waist-hip index ( 34021172 )
  • Waist-to-hip ratio adjusted for BMI ( 34021172 )
  • Waist-to-hip ratio adjusted for BMI (joint analysis for main effect and physical activity interaction) ( 28448500 )
  • Waist-to-hip ratio adjusted for body mass index ( 28448500 )
Novel Interactors 9 novel interactors: MSH5 NEU1 NFKBIL1 NFYA PBX2 PSMB8 SLC27A4 TDP2 WWP2 1 novel interactors: PAK6
Interacting Genes 13 interacting genes: DLL4 EGFL7 ELOC FBXW7 MAML1 MAML2 MAML3 PSEN1 PSEN2 RBPJ SMAD2 SMAD3 SMAD4 2 interacting genes: NOTCH1 NOTCH4
Entrez ID 4855 54567
HPRD ID 01290 05540
Ensembl ID ENSG00000204301 ENSG00000128917
Uniprot IDs A0A1U9X983 Q99466 Q9NR61
PDB IDs 7OR3 7OR5 7OR7 5MVX
GO Terms Enriched among Interactors